US6743779B1
(en)
*
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
BR9711082A
(pt)
|
1996-03-29 |
2000-01-11 |
Lawrence Berkeley National Lab |
Realce de rmn emri na presença de gases mopbres hiperpolarizados.
|
ATE345682T1
(de)
*
|
1996-05-01 |
2006-12-15 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
SE9604610D0
(sv)
*
|
1996-12-16 |
1996-12-16 |
Noviscens Ab |
Medical composition
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
GB9717542D0
(en)
*
|
1997-08-19 |
1997-10-22 |
Nycomed Imaging As |
Process
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
AU1251999A
(en)
|
1997-12-03 |
1999-06-16 |
Britannia Pharmaceuticals Limited |
Improvements in medicaments for asthma treatment
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6153217A
(en)
*
|
1999-01-22 |
2000-11-28 |
Biodelivery Sciences, Inc. |
Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
|
FR2795644B1
(fr)
*
|
1999-07-02 |
2004-07-30 |
Air Liquide Sante Int |
Utilisations therapeutiques d'un melange helium/oxygene, en particulier dans le traitement de l'asthme
|
US6533554B1
(en)
*
|
1999-11-01 |
2003-03-18 |
University Of Southern California |
Thermal transpiration pump
|
US7897140B2
(en)
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
PT1272161E
(pt)
*
|
2000-04-12 |
2008-02-08 |
Liplasome Pharma As |
Sistemas de distribuição de fármacos à base de lípidos que contêm derivados lipídicos degradáveis da fosfolipase a2 para utilização clínica contra infecções parasitárias
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7061237B2
(en)
|
2000-07-13 |
2006-06-13 |
The Regents Of The University Of California |
Remote NMR/MRI detection of laser polarized gases
|
US6652833B2
(en)
*
|
2000-07-13 |
2003-11-25 |
The Regents Of The University Of California |
Functionalized active-nucleus complex sensor
|
DE60141078D1
(de)
*
|
2000-10-04 |
2010-03-04 |
Kyowa Hakko Kirin Co Ltd |
Methode zur beschichtung feiner teilchen mit einem lipidfilm
|
US6849194B2
(en)
|
2000-11-17 |
2005-02-01 |
Pcbu Services, Inc. |
Methods for preparing ethers, ether compositions, fluoroether fire extinguishing systems, mixtures and methods
|
AU3169702A
(en)
*
|
2000-12-07 |
2002-06-18 |
Yamanouchi Europ Bv |
Composition for treatment of inflammatory disorders
|
IL155920A0
(en)
*
|
2000-12-22 |
2003-12-23 |
Aspen Aerogels Inc |
Aerogel powder comprising therapeutic agents
|
NZ529347A
(en)
|
2001-04-04 |
2008-01-31 |
Nordic Vaccine Technology As |
Use of at least one sterol capable of interacting with a nucleic acid and at least saponin to form immunostimulating complexes ( IMSCO )
|
DE10117043A1
(de)
*
|
2001-04-05 |
2002-11-07 |
Gerhard Puetz |
Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
|
US20030166593A1
(en)
*
|
2001-04-30 |
2003-09-04 |
Kenneth Chien |
Non-viral vesicle vector for cardiac specific gene delivery
|
CA2445947A1
(en)
*
|
2001-04-30 |
2002-11-07 |
Targeted Genetics Corporation |
Lipid-comprising drug delivery complexes and methods for their production
|
US7211248B2
(en)
*
|
2001-07-10 |
2007-05-01 |
Sonogene, L.L.C. |
Enhancement of transfection of DNA into the liver
|
US6796957B2
(en)
*
|
2001-07-10 |
2004-09-28 |
Myocardial Therapeutics, Inc. |
Sterile aspiration/reinjection systems
|
US20030068375A1
(en)
*
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
US6680142B2
(en)
*
|
2001-08-24 |
2004-01-20 |
The United States Of America As Represented By The Secretary Of The Navy |
Bio-based microbattery and methods for fabrication of same
|
WO2003032916A2
(en)
*
|
2001-10-16 |
2003-04-24 |
Structural Bioinformatics Inc. |
Organosulfur inhibitors of tyrosine phosphatases
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20060188451A1
(en)
*
|
2001-12-21 |
2006-08-24 |
Aspen Aerogels, Inc. |
Aerogel based pharmaceutical formulations
|
EP1468102B1
(de)
*
|
2002-01-22 |
2009-05-27 |
Biomatera Inc. |
Verfahren zur trocknung von biologisch abbaubaren polymeren
|
JP4113361B2
(ja)
*
|
2002-02-05 |
2008-07-09 |
日立ソフトウエアエンジニアリング株式会社 |
複層半導体ナノ粒子の製造方法
|
US7700074B2
(en)
*
|
2002-02-07 |
2010-04-20 |
Pettegrew Jay W |
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
US7407778B2
(en)
*
|
2002-02-07 |
2008-08-05 |
Pettegrew Jay W |
Compounds, compositions and methods for treating neuropsychiatric disorders
|
WO2003072143A1
(en)
*
|
2002-02-27 |
2003-09-04 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
WO2003075977A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
US20030219473A1
(en)
*
|
2002-03-26 |
2003-11-27 |
Leila Zarif |
Cochleates made with purified soy phosphatidylserine
|
WO2003082303A1
(en)
*
|
2002-03-29 |
2003-10-09 |
Wisconsin Alumni Research Foundation |
Polymeric micelle formulations of hydrophobic compounds and methods
|
AU2003223451A1
(en)
*
|
2002-04-03 |
2003-10-20 |
Jackie R. See |
Methods for ultrasonic imaging and treating diseased tissues
|
EP1499294B1
(de)
*
|
2002-04-29 |
2010-08-11 |
Biotesys Gmbh |
Polymerisierte peptid-modifizierte lipide als biologische transportsysteme für mikronutrients
|
AU2003249641B2
(en)
|
2002-05-16 |
2009-08-20 |
Glycomimetics, Inc. |
Compounds and methods for inhibiting selectin-mediated function
|
US8829198B2
(en)
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
AU2003248747A1
(en)
|
2002-06-27 |
2004-01-19 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
AU2003245595A1
(en)
*
|
2002-07-03 |
2004-01-23 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
PT1521573E
(pt)
*
|
2002-07-15 |
2008-02-08 |
Alcon Inc |
Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular
|
KR100434690B1
(ko)
*
|
2002-07-19 |
2004-06-04 |
소광섭 |
생명체에 대한 자기장의 영향을 측정하는 장치 및 방법
|
US20040137582A1
(en)
*
|
2002-09-16 |
2004-07-15 |
Dordick Jonathan S. |
Methods for manufacturing polysaccharide derivatives
|
JP4886297B2
(ja)
|
2002-11-01 |
2012-02-29 |
バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド |
ジオデート送達媒体
|
DK1593091T3
(da)
*
|
2003-01-25 |
2013-10-28 |
Seno Medical Instr Inc |
Optoakustisk afbildning med høj kontrast ved anvendelse af ikke-sfæriske nanopartikler
|
US8017135B1
(en)
*
|
2003-01-31 |
2011-09-13 |
The Regents Of The University Of California |
Lipid-drug conjugates for local therapy of eye diseases
|
KR101076053B1
(ko)
|
2003-02-04 |
2011-10-21 |
브라코 인터내셔날 비.브이. |
초음파 조영제 및 그것의 제조방법
|
BRPI0408773A
(pt)
*
|
2003-03-24 |
2006-03-28 |
Biosphere Medical Inc |
embolização temporária usando-se polìmeros termossensìveis inverso
|
EP1624858B1
(de)
*
|
2003-04-09 |
2018-06-06 |
Rutgers, the State University of New Jersey |
Neue encochleationsverfahren
|
EP1631669A2
(de)
|
2003-04-09 |
2006-03-08 |
Biodelivery Sciences International, Inc. |
Gegen proteinexpression gerichtete cochleat-zusammensetzungen
|
US20040248877A1
(en)
*
|
2003-04-30 |
2004-12-09 |
Sandeep Gupta |
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
|
WO2004099158A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Monocyclic diazodioxide based bcl-2 protein antagonists
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
US20070129441A1
(en)
*
|
2003-05-06 |
2007-06-07 |
University Of North Texas Health Science Center At Fort Worth |
Protection of cells from adverse external or intrinsic effects, cellular degeneration and death by n-acylethanolamines
|
US20060142395A1
(en)
*
|
2003-05-06 |
2006-06-29 |
University Of North Texas Health Science Center |
Modulation of intracellular calcium signaling by N-acylethanolamines
|
JP4847868B2
(ja)
*
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
US20040228800A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Scicotec Gmbh |
Non-invasive identification of patients at increased risk for myocardial infarction
|
US20060257842A1
(en)
*
|
2003-05-29 |
2006-11-16 |
Pettegrew Jay W |
Cryopreservation media and molecules
|
ATE437884T1
(de)
*
|
2003-05-29 |
2009-08-15 |
Jay W Pettegrew |
Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
WO2004112767A1
(en)
*
|
2003-06-19 |
2004-12-29 |
Advanced Bionutriton Corporation |
Improved absorption of fat-soluble nutrients
|
US20060239913A1
(en)
*
|
2003-06-25 |
2006-10-26 |
Marc Port |
Peptide conjugate for magnetic resonance imaging
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US20060019868A1
(en)
*
|
2004-01-30 |
2006-01-26 |
Pendharkar Sanyog M |
Hemostatic compositions and devices
|
US8440225B2
(en)
*
|
2003-08-07 |
2013-05-14 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
JP2007501797A
(ja)
*
|
2003-08-08 |
2007-02-01 |
バーンズ−ジューイッシュ ホスピタル |
造影及び治療用エマルジョン粒子並びにその使用方法
|
JP4394916B2
(ja)
*
|
2003-09-19 |
2010-01-06 |
独立行政法人科学技術振興機構 |
人工脂質二重膜の形成装置および人工脂質二重膜の形成方法、並びにその利用
|
WO2005046438A2
(en)
*
|
2003-11-06 |
2005-05-26 |
Pluromed, Inc. |
Internal clamp for surgical procedures
|
EP1763533B1
(de)
*
|
2003-11-19 |
2008-01-09 |
GlycoMimetics, Inc. |
Spezifischer antagonist sowohl für e- als auch p-selektine
|
CA2546784A1
(en)
*
|
2003-11-19 |
2005-06-16 |
Glycomimetics, Inc. |
Glycomimetic antagonists for both e- and p-selectins
|
JP5513708B2
(ja)
|
2003-12-22 |
2014-06-04 |
ブラッコ・シュイス・ソシエテ・アノニム |
造影イメージング用の気体封入マイクロベシクル・アセンブリー
|
KR100638041B1
(ko)
*
|
2003-12-24 |
2006-10-23 |
주식회사 삼양사 |
수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
|
WO2005067517A2
(en)
*
|
2004-01-02 |
2005-07-28 |
Wisconsin Alumni Research Foundation |
Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
|
US20050152844A1
(en)
*
|
2004-01-09 |
2005-07-14 |
Barbut Denise R. |
Transpulmonary systemic cooling using liquid mists
|
US20060029656A1
(en)
*
|
2004-02-03 |
2006-02-09 |
Biodelivery Sciences International, Inc. |
Replacement enzyme cochleates
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US7846201B2
(en)
*
|
2004-02-20 |
2010-12-07 |
The Children's Hospital Of Philadelphia |
Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
|
US8562505B2
(en)
|
2004-02-20 |
2013-10-22 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
US9028829B2
(en)
*
|
2004-02-20 |
2015-05-12 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
US20070100457A1
(en)
*
|
2004-03-04 |
2007-05-03 |
Hyde Edward R Jr |
Paramagnetic liquid interface
|
AU2005244262A1
(en)
*
|
2004-04-09 |
2005-11-24 |
Biodelivery Sciences International, Inc. |
Nucleotide-cochleate compositions and methods of use
|
WO2005112913A1
(en)
|
2004-05-20 |
2005-12-01 |
The Scripps Research Institute |
Transthyretin stabilization
|
PL1765292T3
(pl)
|
2004-06-12 |
2018-03-30 |
Collegium Pharmaceutical, Inc. |
Preparaty lecznicze zabezpieczające przed nadużywaniem
|
WO2006009876A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
JP2008503217A
(ja)
|
2004-06-18 |
2008-02-07 |
アンブレツクス・インコーポレイテツド |
新規抗原結合ポリペプチド及びそれらの使用
|
JP2008505916A
(ja)
*
|
2004-07-09 |
2008-02-28 |
メタバシス・セラピューティクス・インコーポレイテッド |
チロシンホスファターゼの酸素/窒素複素環阻害剤
|
GB0418172D0
(en)
*
|
2004-08-13 |
2004-09-15 |
Ic Vec Ltd |
Vector
|
JP4837663B2
(ja)
|
2004-08-18 |
2011-12-14 |
ブラッコ・シュイス・ソシエテ・アノニム |
造影画像化のためのガス充填微小胞組成物
|
WO2006028970A1
(en)
|
2004-09-02 |
2006-03-16 |
Cengent Therapeutics, Inc. |
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
US8440705B2
(en)
|
2004-09-17 |
2013-05-14 |
Whitehead Institute For Biomedical Research |
Compounds, compositions and methods of inhibiting alpha-synuclein toxicity
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
CA2591942A1
(en)
|
2005-01-13 |
2006-07-20 |
Cinvention Ag |
Composite materials containing carbon nanoparticles
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
US20070059775A1
(en)
*
|
2005-03-29 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques
|
JP5242375B2
(ja)
|
2005-04-01 |
2013-07-24 |
ザ レゲントス オブ ザ ユニバーシティ オブ カリフォルニア |
ホスホノ−ペント−2−エン−1−イルヌクレオシド及び類似体
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
WO2006124726A2
(en)
*
|
2005-05-12 |
2006-11-23 |
The General Hospital Corporation |
Novel biotinylated compositions
|
US20090036386A1
(en)
*
|
2005-05-25 |
2009-02-05 |
Glycomimetics, Inc |
Heterobifunctional compounds for selectin inhibition
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US8435558B1
(en)
|
2005-06-28 |
2013-05-07 |
University Of South Florida |
Ultrasound enhancement of drug release across non-ionic surfactant membranes
|
US7981442B2
(en)
*
|
2005-06-28 |
2011-07-19 |
University Of South Florida |
Ultrasound enhancement of drug release across non-ionic surfactant membranes
|
ITPD20050207A1
(it)
|
2005-07-07 |
2007-01-08 |
Fidia Farmaceutici |
Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
|
DK1928892T3
(da)
*
|
2005-08-09 |
2012-01-30 |
Glycomimetics Inc |
Glycomimetiske inhibitorer af PA-IL-lectin PA-IIL-lectin eller begge lectiner fra pseudomonas
|
PT1934236E
(pt)
|
2005-09-02 |
2012-12-26 |
Glycomimetics Inc |
Inibidores de pan-selectina heterobifuncionais
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
CA2624906A1
(en)
*
|
2005-10-18 |
2007-04-26 |
Cinvention Ag |
Thermoset particles and methods for production thereof
|
US20070140974A1
(en)
*
|
2005-12-15 |
2007-06-21 |
General Electric Company |
Targeted nanoparticles for magnetic resonance imaging
|
AU2006330610B2
(en)
|
2005-12-19 |
2012-08-16 |
Pharmain Corporation |
Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
WO2007076160A2
(en)
*
|
2005-12-28 |
2007-07-05 |
Acidophil Llc |
C-10 carbamates of taxanes
|
DK2383271T3
(da)
|
2006-03-13 |
2013-10-07 |
Kyorin Seiyaku Kk |
Aminoquinoloner som GSK-3-inhibitorer
|
EA200870385A1
(ru)
*
|
2006-03-29 |
2009-04-28 |
Фолдркс Фармасьютикалз, Инк. |
Ингибирование токсичности альфа-синуклеина
|
US9789161B2
(en)
*
|
2006-04-28 |
2017-10-17 |
Warsaw Orthopedic, Inc. |
Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
|
US20070259307A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Discus Dental Impressions, Inc. |
Instruments having anti-microbial coating
|
JP5282031B2
(ja)
*
|
2006-05-15 |
2013-09-04 |
ドミトリィ ビー カーポティン |
有機物を含む磁性微粒子
|
US20090176717A1
(en)
*
|
2006-06-01 |
2009-07-09 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
US20100068264A1
(en)
*
|
2006-07-12 |
2010-03-18 |
University Of South Florida |
Niosome-hydrogel drug delivery system
|
EP2053974A2
(de)
|
2006-08-08 |
2009-05-06 |
Keter Medical Ltd. |
Abbildungssystem
|
AU2007290570C1
(en)
|
2006-08-28 |
2013-08-15 |
Kyowa Kirin Co., Ltd. |
Antagonistic human LIGHT-specific human monoclonal antibodies
|
MX2009002960A
(es)
|
2006-09-21 |
2009-06-26 |
Activx Biosciences Inc |
Inhibidores de serina hidrolasa.
|
US7964569B2
(en)
|
2006-10-12 |
2011-06-21 |
Glycomimetics, Inc. |
Glycomimetic replacements for hexoses and N-acetyl hexosamines
|
EP2081893B1
(de)
|
2006-10-19 |
2011-03-23 |
Auspex Pharmaceuticals, Inc. |
Substituierte indole
|
WO2008057604A2
(en)
*
|
2006-11-08 |
2008-05-15 |
The Regents Of The University Of California |
Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
|
EP2099408B1
(de)
*
|
2006-11-28 |
2016-10-05 |
Wisconsin Alumni Research Foundation |
Emulsionen auf fluorpolymerbasis zur intravenösen verabreichung flüchtiger fluorinierter anästhetika
|
US20080181952A1
(en)
*
|
2006-12-11 |
2008-07-31 |
Pluromed, Inc. |
Perfusive Organ Hemostasis
|
CA2673566A1
(en)
|
2006-12-19 |
2008-06-26 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of ccr5 inhibitors
|
CN101611008A
(zh)
*
|
2006-12-22 |
2009-12-23 |
恩希赛弗制药公司 |
C3a受体调节剂及其使用方法
|
US8900562B2
(en)
*
|
2007-01-12 |
2014-12-02 |
Wisconsin Alumni Research Foundation |
Semi-fluorinated block copolymers for delivery of therapeutic agents
|
US7850382B2
(en)
|
2007-01-18 |
2010-12-14 |
Sanford, L.P. |
Valve made from two materials and writing utensil with retractable tip incorporating same
|
AU2008206953A1
(en)
*
|
2007-01-19 |
2008-07-24 |
Cinvention Ag |
Porous, non-degradable implant made by powder molding
|
US7488130B2
(en)
|
2007-02-01 |
2009-02-10 |
Sanford, L.P. |
Seal assembly for retractable instrument
|
NZ598863A
(en)
*
|
2007-02-09 |
2013-11-29 |
Glycomimetics Inc |
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
EP2129768A2
(de)
*
|
2007-02-28 |
2009-12-09 |
Cinvention Ag |
Grossflächiges kultivierungssystem mit oberflächenvergrösserndem substrat
|
BRPI0808089A2
(pt)
*
|
2007-02-28 |
2014-07-15 |
Conatus Pharmaceuticals Inc |
Método para tratar uma doença do fígado, para diminuir um nível elevado de uma enzima do fígado, para inibir uma cascata de sinalização de tnf-alfa e uma cascata de sinalização de alfa-faz, para reduzir um dano ao fígado, para suprimir a apoptose excessiva em uma célula de fígado, e para inibir a replicação do vírus da hepatite c.
|
EP2129766A2
(de)
*
|
2007-02-28 |
2009-12-09 |
Cinvention Ag |
Grossflächiges kultivierungssystem mit füllstoff
|
WO2008104599A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system bag
|
EP2126040A1
(de)
*
|
2007-02-28 |
2009-12-02 |
Cinvention Ag |
Kultivierungssystem mit grosser oberfläche
|
US9814672B2
(en)
*
|
2007-03-09 |
2017-11-14 |
Susan T. Laing |
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
|
ES2605371T3
(es)
|
2007-03-15 |
2017-03-14 |
Auspex Pharmaceuticals, Inc. |
D9-Venlafaxina deuterada
|
FR2914304B1
(fr)
|
2007-03-28 |
2012-11-16 |
Guerbet Sa |
Composes pour le diagnostic de maladies liees a l'expression de vcam.
|
FR2914303A1
(fr)
*
|
2007-03-28 |
2008-10-03 |
Guerbet Sa |
Composes pour le diagnostic de l'apoptose.
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
US20080287931A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Jones Dennis R |
Use of iontophoresis and ultrasound to deliver melanin or other chromophores for laser hair removal
|
JP2010533205A
(ja)
*
|
2007-07-12 |
2010-10-21 |
トラガラ ファーマシューティカルズ,インク. |
癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
|
US8039442B2
(en)
*
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
CN102351880B
(zh)
*
|
2007-09-11 |
2014-11-12 |
杏林制药株式会社 |
作为gsk-3 抑制剂的氰基氨基喹诺酮和四唑并氨基喹诺酮
|
CN102344457B
(zh)
|
2007-09-12 |
2015-07-22 |
杏林制药株式会社 |
作为 gsk-3 抑制剂的螺环状氨基喹诺酮
|
TW200918099A
(en)
*
|
2007-09-14 |
2009-05-01 |
Nitto Denko Corp |
Drug carriers
|
EP2348052A3
(de)
|
2007-09-17 |
2011-10-26 |
The Regents of The University of California |
Auf Prostatazellen in situ abzielende internalisierende humane monoklonale Antikörper
|
US20100286250A1
(en)
*
|
2007-09-26 |
2010-11-11 |
Tufts University |
Fluorinated lipids and methods of use
|
WO2009043031A2
(en)
*
|
2007-09-27 |
2009-04-02 |
Children's Medical Center Corporation |
Microbubbles and methods for oxygen delivery
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
CA2706465A1
(en)
*
|
2007-11-21 |
2009-05-28 |
Pharmaxis Ltd. |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
IL188647A0
(en)
|
2008-01-08 |
2008-11-03 |
Orina Gribova |
Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
WO2009111611A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Proteotech Inc. |
Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
|
EP3147281A1
(de)
*
|
2008-03-17 |
2017-03-29 |
Ambit Biosciences Corporation |
Chinazolinderivate als raf-kinasemodulatoren und verfahren zur verwendung davon
|
US8226312B2
(en)
|
2008-03-28 |
2012-07-24 |
Sanford, L.P. |
Valve door having a force directing component and retractable instruments comprising same
|
WO2009126556A1
(en)
*
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
EP2123258A1
(de)
*
|
2008-05-23 |
2009-11-25 |
Liplasome Pharma A/S |
Liposomen zur Arzneimittelverabreichung
|
EP2318015B1
(de)
*
|
2008-06-13 |
2013-08-07 |
GlycoMimetics, Inc. |
Behandlung von blutkrebs mit ausgewählten glykomimetischen verbindungen
|
WO2010014117A1
(en)
*
|
2008-07-30 |
2010-02-04 |
Nitto Denko Corporation |
Drug carriers
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
US20100069827A1
(en)
|
2008-09-12 |
2010-03-18 |
Barry Neil Silberg |
Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
|
US9446227B2
(en)
|
2008-09-12 |
2016-09-20 |
Sonescence, Inc. |
Ultrasonic dispersion of compositions in tissue
|
US8221012B2
(en)
|
2008-11-07 |
2012-07-17 |
Sanford, L.P. |
Retractable instruments comprising a one-piece valve door actuating assembly
|
WO2010059253A2
(en)
|
2008-11-24 |
2010-05-27 |
Massachusets Institute Of Technology |
Methods and compositions for localized agent delivery
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US8393814B2
(en)
|
2009-01-30 |
2013-03-12 |
Sanford, L.P. |
Retractable instrument having a two stage protraction/retraction sequence
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
CA2752885A1
(en)
|
2009-02-27 |
2010-09-02 |
Ambit Biosciences Corporation |
Jak kinase modulating quinazoline derivatives and methods of use thereof
|
EP2403860B1
(de)
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene und phosphothiazole als hcv polymerase inhibitoren
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
MX2011009414A
(es)
*
|
2009-03-11 |
2011-10-19 |
Kyorin Seiyaku Kk |
7-cicloalquiloaminoquinolonas como inhibidores de gsk-3.
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
RU2011143359A
(ru)
|
2009-03-27 |
2013-05-10 |
Патвэй Терапьютикс, Инк. |
Примидинил- и 1,3,5-триазинилбензимидазолсульфонамиды и их применение в терапии рака
|
NZ595838A
(en)
|
2009-04-22 |
2014-03-28 |
Axikin Pharmaceuticals Inc |
Arylsulfonamide ccr3 antagonists
|
US8399456B2
(en)
|
2009-04-22 |
2013-03-19 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituted arylsulfonamide CCR3 antagonists
|
NZ595823A
(en)
|
2009-04-22 |
2014-03-28 |
Axikin Pharmaceuticals Inc |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
US8410066B2
(en)
*
|
2009-05-01 |
2013-04-02 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
|
CA2760706C
(en)
*
|
2009-05-05 |
2019-08-06 |
Alnylam Pharmaceuticals, Inc. |
Methods of delivering oligonucleotides to immune cells
|
US20100324124A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Compositions and methods relating to DNA-based particles
|
US20100323018A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Branched DNA/RNA monomers and uses thereof
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
TW201105662A
(en)
|
2009-07-07 |
2011-02-16 |
Pathway Therapeutics Ltd |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
US8496973B2
(en)
|
2009-07-08 |
2013-07-30 |
Hope Medical Enterprises, Inc. |
Sodium thiosulfate-containing pharmaceutical compositions
|
MX340134B
(es)
|
2009-07-09 |
2016-06-28 |
Oshadi Drug Administration Ltd |
Composiciones portadoras de matriz, métodos y usos.
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
WO2011017389A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
JP2013502429A
(ja)
|
2009-08-19 |
2013-01-24 |
アムビト ビオスシエンセス コルポラチオン |
ビアリール化合物及びその使用方法
|
US8470817B2
(en)
*
|
2009-10-26 |
2013-06-25 |
Sunesis Pharmaceuticals, Inc. |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
US8871460B2
(en)
|
2009-11-09 |
2014-10-28 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US20110144216A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Honeywell International Inc. |
Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
|
EP2513113B1
(de)
|
2009-12-18 |
2018-08-01 |
Idenix Pharmaceuticals LLC |
Auf 5,5-kondensiertem arylen oder heteroarylen basierende hepatitis-c-virus-hemmer
|
US8710092B2
(en)
*
|
2009-12-23 |
2014-04-29 |
Map Pharmaceuticals, Inc. |
Substituted indolo 4,3 FG quinolines useful for treating migraine
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
DK2542542T3
(en)
|
2010-03-02 |
2015-07-20 |
Axikin Pharmaceuticals Inc |
ISOTOPIC ENRICHED ARYL SULPHONAMIDE CCR3 ANTAGONISTS
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
WO2011116161A2
(en)
|
2010-03-17 |
2011-09-22 |
Axikin Pharmaceuticals Inc. |
Arylsulfonamide ccr3 antagonists
|
US9149432B2
(en)
*
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
US20110229556A1
(en)
*
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
SG184127A1
(en)
*
|
2010-03-19 |
2012-10-30 |
Massachusetts Inst Technology |
Lipid vesicle compositions and methods of use
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
AU2011261499B2
(en)
|
2010-06-01 |
2015-07-16 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
EP2585063A1
(de)
|
2010-06-01 |
2013-05-01 |
Biotheryx Inc. |
Verfahren zur behandlung von hämatologischen malignomen mit 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridon
|
MX2012014273A
(es)
|
2010-06-07 |
2013-03-22 |
Novomedix Llc |
Compuestos furanilo y su uso.
|
CA2805745C
(en)
|
2010-07-19 |
2019-01-15 |
Summa Health System |
Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
|
US20130225615A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
2-cycloquinazoline derivatives and methods of use thereof
|
WO2012030924A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
US20130225614A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
US20130225578A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
CA2809983A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Hydrobromide salts of a pyrazolylaminoquinazoline
|
AU2011296074B2
(en)
|
2010-09-01 |
2015-06-18 |
Ambit Biosciences Corporation |
An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
EP2663553B1
(de)
|
2010-09-01 |
2015-08-26 |
Ambit Biosciences Corporation |
Chinolin- und isochinolinverbindungen zur verwendung als jak-modulatoren
|
US20130317045A1
(en)
|
2010-09-01 |
2013-11-28 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
US8633207B2
(en)
|
2010-09-01 |
2014-01-21 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
WO2012030918A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
CA2814011A1
(en)
|
2010-10-11 |
2012-04-19 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
BR112013014021A8
(pt)
|
2010-12-06 |
2017-10-03 |
Follica Inc |
Métodos para tratamento de calvície e promoção de crescimento de cabelos
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
PT2826467T
(pt)
|
2010-12-22 |
2017-10-25 |
Purdue Pharma Lp |
Formas envolvidas de dosamento de libertação controlada resistentes à adulteração
|
NZ612996A
(en)
|
2010-12-23 |
2015-05-29 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
EP3763740A1
(de)
|
2011-01-26 |
2021-01-13 |
Celldex Therapeutics, Inc. |
Anti-kit-antikörper und verwendungen davon
|
MX2013006020A
(es)
|
2011-01-31 |
2013-10-01 |
Celgene Corp |
Composicion farmaceutica de analogos de citidina y metodos para su uso.
|
WO2012109398A1
(en)
|
2011-02-10 |
2012-08-16 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
|
EP2684048B1
(de)
|
2011-03-11 |
2018-10-03 |
Board of Regents of the University of Nebraska |
Biomarker für koronare herzkrankheit
|
US20140088103A1
(en)
|
2011-03-28 |
2014-03-27 |
Mei Pharma, Inc. |
(fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
WO2012135175A1
(en)
|
2011-03-28 |
2012-10-04 |
Pathway Therapeutics Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
AU2012236834B2
(en)
|
2011-03-28 |
2015-12-10 |
Mei Pharma, Inc |
(alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
MX2013015373A
(es)
|
2011-06-23 |
2014-02-11 |
Map Pharmaceuticals Inc |
Nuevos analogos de fluoroergolina.
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
CA2851155C
(en)
|
2011-10-14 |
2021-02-23 |
Ambit Biosciences Corporation |
Heterocyclic compounds and methods of use thereof
|
SG10201509139QA
(en)
|
2011-12-19 |
2015-12-30 |
Map Pharmaceuticals Inc |
Novel iso-ergoline derivatives
|
WO2013095708A1
(en)
|
2011-12-21 |
2013-06-27 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
AU2012358150B2
(en)
|
2011-12-22 |
2017-07-20 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
US9365556B2
(en)
|
2012-03-16 |
2016-06-14 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
US10357450B2
(en)
|
2012-04-06 |
2019-07-23 |
Children's Medical Center Corporation |
Process for forming microbubbles with high oxygen content and uses thereof
|
RS57086B1
(sr)
|
2012-05-02 |
2018-06-29 |
Boehringer Ingelheim Int |
Supstituisani 3-haloalilamin inhibitori ssao i njihova primena
|
WO2013169479A1
(en)
*
|
2012-05-11 |
2013-11-14 |
Massachusetts Institute Of Technology |
Compositions and methods of treatment of drug resistant cancers
|
WO2013188470A1
(en)
*
|
2012-06-11 |
2013-12-19 |
The Regents Of The University Of California |
Method and system for in vivo hydrogen peroxide detection with ultrasound
|
EP2861562B1
(de)
|
2012-06-14 |
2018-05-09 |
Mayo Foundation For Medical Education And Research |
Pyrazolderivate als hemmer von stat3
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
CN110256559B
(zh)
|
2012-07-25 |
2023-05-26 |
塞尔德克斯医疗公司 |
抗kit抗体及其用途
|
ES2688397T3
(es)
|
2012-07-30 |
2018-11-02 |
Matinas Biopharma Nanotechnologies, Inc. |
Cocleatos hechos con fosfatidilserina de soja
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
JP6431480B2
(ja)
|
2012-08-31 |
2018-11-28 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病の治療および診断のためのビオチン複合体
|
TW201414721A
(zh)
|
2012-09-07 |
2014-04-16 |
Axikin Pharmaceuticals Inc |
同位素濃化之芳磺醯胺ccr3拮抗劑
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
CA2890177A1
(en)
|
2012-11-08 |
2014-05-15 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
JP6313779B2
(ja)
|
2012-11-30 |
2018-04-18 |
ノボメディックス, エルエルシーNovomedix, Llc |
置換ビアリールスルホンアミドおよびその利用
|
ES2668045T3
(es)
|
2012-12-07 |
2018-05-16 |
Glycomimetics, Inc. |
Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
EP2934143A4
(de)
|
2012-12-21 |
2016-06-15 |
Map Pharmaceuticals Inc |
Neuartige methysergidderivate
|
WO2014110305A1
(en)
|
2013-01-11 |
2014-07-17 |
Mayo Foundation For Medical Education And Research |
Vitamins c and k for treating polycystic diseases
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144364A1
(en)
|
2013-03-15 |
2014-09-18 |
Children's Medical Center Corporation |
Gas-filled stabilized particles and methods of use
|
AU2014274660B2
(en)
|
2013-06-06 |
2019-05-16 |
Pierre Fabre Médicament |
Anti-C10orf54 antibodies and uses thereof
|
MX2016002626A
(es)
|
2013-08-30 |
2016-06-06 |
Ambit Biosciences Corp |
Compuestos de biarilacetamida y metodos de uso de los mismos.
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
WO2015048498A2
(en)
|
2013-09-27 |
2015-04-02 |
Massachusetts Institute Of Technology |
Carrier-free biologically-active protein nanostructures
|
WO2015127351A1
(en)
|
2014-02-24 |
2015-08-27 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
WO2015134560A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
TWI807150B
(zh)
|
2014-03-20 |
2023-07-01 |
美商卡佩拉醫療公司 |
苯并咪唑衍生物及其醫藥組合物及使用方法
|
CN106661027B
(zh)
|
2014-03-20 |
2019-12-24 |
卡佩拉医疗公司 |
苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
|
US9522114B1
(en)
|
2014-03-27 |
2016-12-20 |
University Of South Florida |
Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin
|
AU2015259471A1
(en)
|
2014-05-12 |
2016-11-24 |
Conatus Pharmaceuticals, Inc. |
Treatment of the complications of chronic liver disease with caspase inhibitors
|
DK3148579T3
(da)
|
2014-05-28 |
2021-03-08 |
Agenus Inc |
Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
|
WO2015187968A1
(en)
|
2014-06-04 |
2015-12-10 |
Sonescence, Inc. |
Systems and methods for therapeutic agent delivery
|
US9527815B2
(en)
|
2014-06-18 |
2016-12-27 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
WO2016025129A1
(en)
|
2014-08-14 |
2016-02-18 |
Alhamadsheh Mamoun M |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
MX2017003215A
(es)
|
2014-09-12 |
2018-01-24 |
Tobira Therapeutics Inc |
Terapia de combinacion con cenicriviroc para el tratamiento de la fibrosis.
|
EP3209658A1
(de)
|
2014-10-24 |
2017-08-30 |
Biogen MA Inc. |
Diterpenoidderivate und verfahren zur verwendung
|
PL3227310T3
(pl)
|
2014-12-03 |
2020-02-28 |
Glycomimetics, Inc. |
Heterodwufunkcyjne inhibitory selektyn E i receptorów chemokinowych CXCR4”
|
PT3333191T
(pt)
|
2014-12-11 |
2020-12-15 |
Pf Medicament |
Anticorpos anti-c10orf54 e suas utilizações
|
US10221248B2
(en)
|
2014-12-22 |
2019-03-05 |
The Rockefeller University |
Anti-MERTK agonistic antibodies and uses thereof
|
KR102034202B1
(ko)
|
2014-12-23 |
2019-10-18 |
에스엠에이 세라퓨틱스 아이엔씨. |
3,5-디아미노피라졸 키나제 억제제
|
US9657020B2
(en)
|
2015-01-20 |
2017-05-23 |
Xoc Pharmaceuticals, Inc. |
Ergoline compounds and uses thereof
|
CN107405346A
(zh)
|
2015-01-20 |
2017-11-28 |
Xoc制药股份有限公司 |
异麦角灵化合物及其用途
|
AU2016212526B2
(en)
|
2015-01-28 |
2020-11-05 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd |
Substituted imidazo (1, 2-a) pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
|
SG10201907901XA
(en)
|
2015-03-03 |
2019-10-30 |
Kymab Ltd |
Antibodies, uses & methods
|
RS60792B1
(sr)
|
2015-05-29 |
2020-10-30 |
Agenus Inc |
Anti-ctla-4 antitela i postupci za njihovu primenu
|
CN107635472A
(zh)
|
2015-06-19 |
2018-01-26 |
神经系统分析公司 |
经颅多普勒探测器
|
EA036837B1
(ru)
|
2015-06-23 |
2020-12-25 |
Нейрокрин Байосайенсиз, Инк. |
Ингибиторы vmat2 для лечения неврологических заболеваний или расстройств
|
AU2016305087B2
(en)
|
2015-08-12 |
2022-01-20 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
US10323091B2
(en)
|
2015-09-01 |
2019-06-18 |
Agenus Inc. |
Anti-PD-1 antibodies and methods of use thereof
|
EA201890852A1
(ru)
|
2015-10-30 |
2018-10-31 |
Нейрокрин Байосайенсиз, Инк. |
Соли валбеназина и их полиморфы
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US11474102B2
(en)
*
|
2015-11-23 |
2022-10-18 |
Massachusetts Institute Of Technology |
Protein corona phase molecular recognition
|
FI3383920T3
(fi)
|
2015-11-30 |
2024-04-10 |
The Regents Of The Univ Of California |
Kasvainspesifinen hyötyaineen antaminen ja immuuniaktivointi käyttämällä erittäin spesifiseen kasvainsolun pinta-antigeeniin kohdentuvaa ihmisen vasta-ainetta
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
PL3394057T3
(pl)
|
2015-12-23 |
2022-08-22 |
Neurocrine Biosciences, Inc. |
Sposób syntetyczny wytwarzania di(4-metylobenzenosulfonianu) (S)-2-amino-3-metylobutanianu (2R,3R,11bR)-3-izobutylo-9,10-dimetoksy-2,3,4,6,7,11b-heksahydro-1H-pirydo[2,1-a]izochinolin-2-ylu
|
SG11201805480TA
(en)
|
2015-12-31 |
2018-07-30 |
Conatus Pharmaceuticals Inc |
Methods of using caspase inhibitors in treatment of liver disease
|
CN108778140A
(zh)
|
2016-01-05 |
2018-11-09 |
神经系统分析公司 |
用于确定临床指征的系统和方法
|
US11589836B2
(en)
|
2016-01-05 |
2023-02-28 |
Novasignal Corp. |
Systems and methods for detecting neurological conditions
|
CN108778141A
(zh)
|
2016-01-05 |
2018-11-09 |
神经系统分析公司 |
集成化探针结构
|
US9938254B2
(en)
|
2016-01-08 |
2018-04-10 |
Celgene Corporation |
Antiproliferative compounds, and their pharmaceutical compositions and uses
|
AR107320A1
(es)
|
2016-01-08 |
2018-04-18 |
Celgene Corp |
Formas sólidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos
|
WO2017127422A1
(en)
|
2016-01-22 |
2017-07-27 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of pa-il and pa-iil lectins
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
WO2017151836A1
(en)
|
2016-03-04 |
2017-09-08 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
JP2019510085A
(ja)
|
2016-03-08 |
2019-04-11 |
ロス ガトス ファーマスーティカルズ, インク.Los Gatos Pharmaceuticals, Inc. |
癌治療のためのナノ粒子ならびに方法および化合物
|
WO2017156183A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
WO2017180589A1
(en)
|
2016-04-11 |
2017-10-19 |
Auspex Pharmaceuticals, Inc. |
Deuterated ketamine derivatives
|
WO2017180794A1
(en)
|
2016-04-13 |
2017-10-19 |
Skyline Antiinfectives, Inc. |
Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
|
EP3454904B1
(de)
|
2016-05-13 |
2022-12-14 |
Institut Pasteur |
Hemmung von beta-2-nicotinischen acetylcholinrezeptoren zur behandlung von morbus alzheimer
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
CA3024508A1
(en)
|
2016-05-27 |
2017-11-30 |
Agenus Inc. |
Anti-tim-3 antibodies and methods of use thereof
|
WO2017218533A1
(en)
|
2016-06-13 |
2017-12-21 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
CA3030099A1
(en)
|
2016-07-08 |
2018-01-11 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
WO2018031445A1
(en)
|
2016-08-08 |
2018-02-15 |
Glycomimetics, Inc. |
Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
|
US10919904B2
(en)
|
2016-08-17 |
2021-02-16 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
WO2018053460A1
(en)
*
|
2016-09-19 |
2018-03-22 |
The Regents Of The University Of California |
Paramagnetic polymers
|
MX2019003134A
(es)
|
2016-09-19 |
2019-08-29 |
Mei Pharma Inc |
Terapia de combinacion.
|
KR102607640B1
(ko)
|
2016-10-07 |
2023-11-28 |
글리코미메틱스, 인크. |
매우 강력한 다량체성 e-셀렉틴 길항물질
|
EP3526256A1
(de)
|
2016-10-11 |
2019-08-21 |
Agenus Inc. |
Anti-lag-3-antikörper und verfahren zur verwendung davon
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
KR102539159B1
(ko)
|
2016-11-07 |
2023-06-02 |
주식회사 뉴라클사이언스 |
서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법
|
WO2018089427A1
(en)
|
2016-11-09 |
2018-05-17 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
US10106521B2
(en)
|
2016-11-09 |
2018-10-23 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
US10799503B2
(en)
|
2016-12-01 |
2020-10-13 |
Ignyta, Inc. |
Methods for the treatment of cancer
|
EP3548027A1
(de)
|
2016-12-02 |
2019-10-09 |
Neurocrine Biosciences, Inc. |
Verwendung von valbenazin zur behandlung von schizophrenie oder schizoaffektiver störung
|
BR112019011582A2
(pt)
|
2016-12-07 |
2019-10-22 |
Agenus Inc. |
anticorpos e métodos de utilização dos mesmos
|
KR20230037664A
(ko)
|
2016-12-07 |
2023-03-16 |
아게누스 인코포레이티드 |
항-ctla-4 항체 및 이의 사용 방법
|
KR20190108148A
(ko)
|
2017-01-27 |
2019-09-23 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
JP7157752B2
(ja)
|
2017-02-17 |
2022-10-20 |
エイドス セラピューティクス,インコーポレイティド |
Ag-10、その中間体及びその塩の調製方法
|
CA3053332A1
(en)
|
2017-02-17 |
2018-08-23 |
CAMRIS International, Inc. |
Universal antivenom
|
US11147890B2
(en)
|
2017-02-28 |
2021-10-19 |
Children's Medical Center Corporation |
Stimuli-responsive particles encapsulating a gas and methods of use
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
EP3596096A1
(de)
|
2017-03-15 |
2020-01-22 |
GlycoMimetics, Inc. |
Galactopyranosyl-cyclohexyl-derivate als e-selectin-antagonisten
|
CN110612309A
(zh)
|
2017-03-27 |
2019-12-24 |
细胞基因公司 |
用于降低免疫原性的方法和组合物
|
CA3059366A1
(en)
|
2017-04-13 |
2018-10-18 |
Agenus Inc. |
Anti-cd137 antibodies and methods of use thereof
|
CA3059133A1
(en)
|
2017-04-21 |
2018-10-25 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
ES2952961T3
(es)
|
2017-05-01 |
2023-11-07 |
Agenus Inc |
Anticuerpos anti-TIGIT y métodos de uso de los mismos
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
JP2020522504A
(ja)
|
2017-06-01 |
2020-07-30 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc |
多環式化合物およびそれらの用途
|
KR102472683B1
(ko)
|
2017-06-27 |
2022-12-01 |
주식회사 뉴라클사이언스 |
녹내장의 치료를 위한 항-서열 유사성 19를 가진 패밀리, 멤버 a5 항체의 용도
|
WO2019003159A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTI-FAM19A5 ANTIBODIES FOR THE TREATMENT OF FIBROSIS
|
EP3645040A4
(de)
|
2017-06-27 |
2021-05-05 |
Neuracle Science Co., Ltd |
Verwendung von anti-fam19a5-antikörpern zur krebsbehandlung
|
JP7076059B2
(ja)
|
2017-06-27 |
2022-05-27 |
ニューラクル サイエンス カンパニー リミテッド |
抗fam19a5抗体及びその用途
|
AU2018324070B2
(en)
|
2017-09-01 |
2023-05-18 |
East Carolina University |
Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
|
EP3678701A4
(de)
|
2017-09-05 |
2021-12-01 |
Torque Therapeutics, Inc. |
Therapeutische proteinzusammensetzungen und verfahren zur herstellung und verwendung davon
|
IL273300B1
(en)
|
2017-09-21 |
2024-02-01 |
Neurocrine Biosciences Inc |
High dose valbenazine formulation and related preparations, methods and kits
|
SG11202003194YA
(en)
|
2017-10-10 |
2020-05-28 |
Neurocrine Biosciences Inc |
Methods for the administration of certain vmat2 inhibitors
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
AU2018361957B2
(en)
|
2017-10-31 |
2023-05-25 |
Staten Biotechnology B.V. |
Anti-ApoC3 antibodies and methods of use thereof
|
JP7275131B2
(ja)
|
2017-11-30 |
2023-05-17 |
グリコミメティクス, インコーポレイテッド |
骨髄浸潤リンパ球を動員する方法、およびその使用
|
BR112020013198A2
(pt)
|
2017-12-29 |
2020-12-01 |
Glycomimetics, Inc. |
inibidores heterobifuncionais de e-selectina e galectina-3
|
CA3087856A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics, Llc |
Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
|
WO2019139871A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics Llc |
Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications
|
WO2019173229A1
(en)
|
2018-03-05 |
2019-09-12 |
Glycomimetics, Inc. |
Methods for treating acute myeloid leukemia and related conditions
|
MX2020009844A
(es)
|
2018-03-23 |
2021-01-15 |
Eidos Therapeutics Inc |
Metodos para tratar amiloidosis por transtiretina (ttr) usando ag10.
|
JP7171081B2
(ja)
|
2018-04-24 |
2022-11-15 |
ニューラクル サイエンス カンパニー リミテッド |
神経病性疼痛の治療のための配列類似性19、メンバーa5抗体を有する抗ファミリーの用途
|
MX2020013004A
(es)
|
2018-06-14 |
2021-02-17 |
Neurocrine Biosciences Inc |
Compuestos inhibidores del transportador de monoamina 2 (vmat2), composiciones, y metodos relacionados con los mismos.
|
EP3814327A1
(de)
|
2018-06-29 |
2021-05-05 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen
|
BR112021000934A2
(pt)
|
2018-07-20 |
2021-04-27 |
Pierre Fabre Medicament |
receptor para vista
|
TW202021585A
(zh)
|
2018-08-15 |
2020-06-16 |
美商紐羅克里生物科學有限公司 |
用於特定vmat2抑制劑之投與之方法
|
BR112020026493A2
(pt)
|
2018-08-17 |
2021-03-23 |
Eidos Therapeutics, Inc. |
Formulações de ag10
|
AU2019352017A1
(en)
|
2018-10-03 |
2021-05-06 |
Staten Biotechnology B.V. |
Antibodies specific for human and cynomolgus ApoC3 and methods of use thereof
|
AU2019379325A1
(en)
|
2018-11-16 |
2021-06-03 |
Genexine, Inc. |
Method of treating a tumor with a combination of IL-7 protein and an immune checkpoint inhibitor
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
WO2020132071A1
(en)
|
2018-12-19 |
2020-06-25 |
Shy Therapeutics. Llc |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
|
WO2020139962A1
(en)
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|
US11447468B2
(en)
|
2019-02-06 |
2022-09-20 |
Dice Alpha, Inc. |
IL-17 ligands and uses thereof
|
US11242407B2
(en)
|
2019-02-26 |
2022-02-08 |
Inspirna, Inc. |
High-affinity anti-MERTK antibodies and uses thereof
|
EP3935042A1
(de)
|
2019-03-07 |
2022-01-12 |
Conatus Pharmaceuticals, Inc. |
Caspase-inhibitoren und verfahren zur verwendung davon
|
US20220152226A1
(en)
*
|
2019-03-27 |
2022-05-19 |
The Texas A&M University System |
Intracellular delivery and mitochondrial targeting by fluorination
|
CA3138403A1
(en)
|
2019-05-20 |
2020-11-26 |
Christopher J. MACNEVIN |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
AU2020310190A1
(en)
|
2019-07-11 |
2022-02-24 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US20220274922A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
CN114585644A
(zh)
|
2019-08-30 |
2022-06-03 |
艾吉纳斯公司 |
抗cd96抗体及其使用方法
|
EP4031534A1
(de)
|
2019-09-16 |
2022-07-27 |
Dice Alpha, Inc. |
Il-17a-modulatoren und verwendungen davon
|
WO2021146191A1
(en)
|
2020-01-13 |
2021-07-22 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and a bispecific antibody
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
IL294944A
(en)
|
2020-01-28 |
2022-09-01 |
Genentech Inc |
Il15/il15r alpha heterodimeric fc-fused proteins for cancer therapy
|
US20230210952A1
(en)
|
2020-02-05 |
2023-07-06 |
Washington University |
Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
|
EP4157271A1
(de)
|
2020-05-29 |
2023-04-05 |
Boulder Bioscience LLC |
Verfahren zur verbesserten endovaskulären thrombektomie mit 3,3'-diindolylmethan
|
WO2021257828A1
(en)
|
2020-06-18 |
2021-12-23 |
Shy Therapeutics, Llc |
Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
BR112023002346A2
(pt)
|
2020-08-07 |
2023-05-02 |
Fortis Therapeutics Inc |
Imunoconjugados direcionados a cd46 e métodos de uso dos mesmos
|
US20240025863A1
(en)
|
2020-09-16 |
2024-01-25 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
TW202231269A
(zh)
|
2020-10-23 |
2022-08-16 |
美商拜歐斯瑞克斯公司 |
Kras蛋白降解劑、其醫藥組合物及其治療應用
|
KR20230104176A
(ko)
|
2020-11-02 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
코로나바이러스의 치료를 위한 인터류킨-7의 용도
|
AU2021376396A1
(en)
|
2020-11-05 |
2023-06-08 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
|
JP2024500377A
(ja)
|
2020-12-14 |
2024-01-09 |
バイオセリックス, インコーポレイテッド |
Pde4分解剤、医薬組成物、及び治療的応用
|
CN114762679B
(zh)
*
|
2021-01-13 |
2023-04-07 |
上海交通大学医学院 |
一种纳米复合物及其制备方法和用途
|
EP4284377A1
(de)
|
2021-01-27 |
2023-12-06 |
Shy Therapeutics LLC |
Verfahren zur behandlung von fibrotischen erkrankungen
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
CN117642396A
(zh)
|
2021-03-10 |
2024-03-01 |
戴斯分子Sv有限公司 |
αVβ6和αVβ1整联蛋白抑制剂及其用途
|
WO2022226166A1
(en)
|
2021-04-22 |
2022-10-27 |
Protego Biopharma, Inc. |
Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis
|
WO2022251533A1
(en)
|
2021-05-27 |
2022-12-01 |
Protego Biopharma, Inc. |
Heteroaryl diamide ire1/xbp1s activators
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR20240027676A
(ko)
|
2021-06-02 |
2024-03-04 |
라이엘 이뮤노파마, 인크. |
Nr4a3-결핍 면역 세포 및 이의 용도
|
CA3218481A1
(en)
|
2021-06-14 |
2022-12-22 |
argenx BV |
Anti-il-9 antibodies and methods of use thereof
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022266248A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2023055045A1
(ko)
|
2021-09-29 |
2023-04-06 |
주식회사 엔바이오스 |
코일드 코일 융합 단백질
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
WO2023129577A1
(en)
|
2022-01-03 |
2023-07-06 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
TW202342070A
(zh)
|
2022-03-30 |
2023-11-01 |
美商拜奧馬林製藥公司 |
肌萎縮蛋白外顯子跳躍寡核苷酸
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
US20230331693A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
US20230399362A1
(en)
|
2022-06-13 |
2023-12-14 |
B.A.I. Laboratories, Llc |
Interleukin-13 binding cyclic oligopeptides and methods of use thereof
|
WO2024054832A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS
|
WO2024073473A1
(en)
|
2022-09-30 |
2024-04-04 |
Boulder Bioscience Llc |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|